AKBA

AKBA

USD

Akebia Therapeutics Inc. Common Stock

$2.125+0.025 (1.190%)

リアルタイム価格

Healthcare
Drug Manufacturers - Specialty & Generic
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$2.100

高値

$2.145

安値

$2.070

出来高

4.47M

企業ファンダメンタルズ

時価総額

563.4M

業種

Drug Manufacturers - Specialty & Generic

United States

取引統計

平均出来高

4.04M

取引所

NCM

通貨

USD

52週レンジ

安値 $1.52現在値 $2.125高値 $4.079

関連ニュース

GlobeNewswire

Akebia Therapeutics to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced

もっと見る
Akebia Therapeutics to Present at Upcoming Investor Conferences
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Akebia Therapeutics, Lowers Price Target to $6

HC Wainwright & Co. analyst Matthew Caufield maintains Akebia Therapeutics with a Buy and lowers the price target from $8 to $6.

もっと見る
HC Wainwright & Co. Maintains Buy on Akebia Therapeutics, Lowers Price Target to $6
Analyst Upgrades

BTIG Maintains Buy on Akebia Therapeutics, Lowers Price Target to $5

BTIG analyst Julian Harrison maintains Akebia Therapeutics with a Buy and lowers the price target from $10 to $5.

もっと見る
BTIG Maintains Buy on Akebia Therapeutics, Lowers Price Target to $5
GlobeNewswire

Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients

CAMBRIDGE, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced

もっと見る
Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients